Received May 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 3553D | — |
A 17 years old male patient received an expired dose of Menveo; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 17-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number 3553D, expiry date 28-FEB-2025) for prophylaxis. On 05-MAY-2025, the patient received Menveo. On 05-MAY-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: A 17 years old male patient received an expired dose of Menveo). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 05-MAY-2025 A clinical manager called to report the administration of an expired dose of Menveo (1 vial) to a patient on the day of reporting, which led to an expired vaccine used. The reporter wanted to know how long they have to wait to revaccinate the patient.